Cridanimod sodium T5317L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Cridanimod can increase progesterone receptor (PR) expression, with potential antineoplastic adjuvant activity. Cridanimod is able to induce the expression of PR in endometrial cancer. In combination with a progestin, cancer cells could be eradicated thro
CAS nr:
58880-43-6
Purity:
98%
Molecular Weight:
275,23
SMILES:
O=C([O-])CN(C1=C2C=CC=C1)C3=CC=CC=C3C2=O.[Na+]
Formula:
C15H10NNaO3
Pathway:
Target:
